antipyrine has been researched along with propofol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| He, YL; Seno, H; Tashiro, C; Tsujimoto, S | 1 |
| Ikeda, Y | 1 |
| Fu, JQ; Liu, H; Wang, DF | 1 |
| Cheng, X; Feng, D; Hu, X; Ma, L; Peng, Y; Shao, F; Sun, J; Wan, P; Wang, G; Wang, X; Wu, H; Zhang, R; Zhu, J; Zhu, Y | 1 |
| Liu, XL; Song, X; Wang, DF; Yao, N | 1 |
8 other study(ies) available for antipyrine and propofol
| Article | Year |
|---|---|
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
The effects of uterine and umbilical blood flows on the transfer of propofol across the human placenta during in vitro perfusion.
Topics: Adult; Algorithms; Anesthetics, Intravenous; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Blood Glucose; Female; Humans; In Vitro Techniques; Lactates; Perfusion; Pregnancy; Propofol; Regional Blood Flow; Umbilical Arteries; Uterus | 2001 |
[Electron spin resonance method and brain diseases].
Topics: Animals; Antipyrine; Brain Diseases; Edaravone; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Free Radicals; Humans; Phosphodiesterase Inhibitors; Propofol; Rats | 2006 |
[A comparison of protective effect of propofol and edaravone pretreatment against cerebral ischemia-reperfusion injury].
Topics: Animals; Antipyrine; Apoptosis; Brain Ischemia; Cell Survival; Cells, Cultured; Cerebral Cortex; Edaravone; Neurons; Propofol; Rats; Reperfusion Injury | 2008 |
Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Topics: Androsterone; Antipyrine; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Edaravone; Estradiol; Glucuronides; Glucuronosyltransferase; Humans; Isoenzymes; Kidney; Kinetics; Metabolic Clearance Rate; Microsomes; Microsomes, Liver; Molecular Structure; Naloxone; Propofol; Tandem Mass Spectrometry; UDP-Glucuronosyltransferase 1A9 | 2012 |
[Neuroprotective effects of combined pretreatment with edaravone and propofol on neonatal rat cerebral cortical neurons with ischemia/reperfusion injury in vitro].
Topics: Animals; Antipyrine; Apoptosis; Brain Ischemia; Cell Survival; Cells, Cultured; Cerebral Cortex; Edaravone; Neurons; Neuroprotective Agents; Propofol; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2012 |